Clinical Trials Directory

Trials / Completed

CompletedNCT00748033

A Study Evaluating a Urinary Catheter With Different Activation Times for the Wetting Solution, in Healthy Male Volunteers.

A Randomized, Single-blind, Cross-over, Single-centre Study in Healthy Volunteers Evaluating Subject Perception and Friction at Withdrawal of Catheters With Different Activation Times Compared to a Reference Catheter

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Wellspect HealthCare · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary purpose of this study is to compare the subject's perception (separately for each randomized catheter) of practicing catheterization when using catheters with sodium chloride in wetting solution (using two different activation times) with a standard reference catheter. The hypothesis is that the subjects' perception of catheterization is the same or more positive when using the test catheters compared to the reference catheter.

Detailed description

The study is designed as a randomized, single-blind, cross-over, single-centre, study in healthy male volunteers. All subjects will first be catheterized with a reference catheter, which is proven to be well tolerated by most subjects. This catheter will be used as a reference catheter to be compared with the randomized catheters. One more reason for this first test is to withdraw subjects who cannot tolerate catheterizations. Subjects will qualify for the randomized part of the study only if the first catheterization could be performed without significant discomfort. When the subject is randomized he will be catheterized with two urinary catheters in a randomized order during one day. The activation times for the wetting solution will be 5 seconds and 24 (± 2h) hours. During each catheterization, the friction at withdrawal will be measured for the catheter using a Tension Test System. The subjects will be blinded. 25 healthy volunteers will be recruited from a single centre in Sweden.

Conditions

Interventions

TypeNameDescription
DEVICEReference catheter: LoFric PVC, Nelaton 40 cm, CH 12The subjects were first catheterized with this reference catheter.
DEVICELoFric POBE Hydro-Kit II, 5 secondsAn unsalted LoFric POBE Hydro-Kit II, Nelaton 40 cm, CH 12 with sodium chloride in wetting solution, activation time 5 seconds
DEVICELoFric POBE Hydro-Kit II, 24 hoursAn unsalted LoFric POBE Hydro-Kit II, Nelaton 40 cm, CH 12 with sodium chloride in wetting solution, activation time 24 hours

Timeline

Start date
2008-08-01
Primary completion
2008-08-01
Completion
2008-08-01
First posted
2008-09-08
Last updated
2021-05-06
Results posted
2021-05-06

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT00748033. Inclusion in this directory is not an endorsement.